Semochkin SV. Perspectives for the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma. Clinical Oncohematology [Internet]. 2024 Feb. 20 [cited 2024 Dec. 8];16(3):229-41. Available from: https://bloodjournal.ru/index.php/coh/article/view/30